Skip to main content
Share
Print this page
Email this page link to a friend
FaceBook
Tweet this

William I. Bensinger, MD

Medical Oncologist
Languages: English
Accepting New Patients
Professional Statement
It’s important for patients to have as much information as they want to know about their disease so that they can make decisions about their care based on knowledge. Today the treatment outlook for patients with multiple myeloma has never been brighter, however, the many new drugs that are now available and the soon to be approved drugs on the horizon makes choosing the right combinations somewhat complicated. By learning about their illness and the many treatments available, patients can receive the best most up to date care while minimizing the side effects of therapy.
Education
Institution
Type
Field of Study
Year
Northwestern University Medical School
Medical School
1973
Washington University School of Medicine
Internship
1974
University of Washington School of Medicine
Residency
Oncology/Hematology
1979
Board Certifications
  • American Board of Internal Medicine, Oncology
  • American Board of Internal Medicine, Internal Medicine
Services
Clinical Interests
  • allogenic bone marrow transplant
  • amyloidosis
  • anemia
  • b12 deficiency anemia
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer survivorship
  • egfr mutation
  • endocrine complications of cancer therapy
  • hellp syndrome
  • hemochromatosis
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • hypogammaglobulinemia
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • leukopenia
  • maternal hematologic disorders
  • multiple myeloma
  • myelodysplasia
  • myelodysplastic syndrome
  • neutropenia
  • pancytopenia
  • paroxysmal nocturnal hemoglobinuria
  • petechiae
  • plasma cell dyscrasia
  • polycythemia
  • pulmonary metastases
  • purpura
  • rh incompatibility
  • secondary polycythemia
  • splenomegaly
  • stem cell transplant
  • teratogen exposure
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • unknown primary cancer
PATIENT RATINGS AND COMMENTS

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.6 out of 5 (61 Ratings, 9 Comments)


100

08/16/2017
[...] how lucky I am - or anyone else under Dr. Wm. Bensinger. Great! Just great!
100

08/09/2017
I feel Dr. Bensinger has my best interests and is doing all he can for me.
100

05/31/2017
Dr. Bensinger was patient, sincerely interested in me and my concerns. He responded clearly and thoroughly in understandable language.
30

05/22/2017
He did not answer my questions directly and when he did finally arrive, he seemed distracted and hurried.
60

05/01/2017
Very knowledgeable and experienced with his area of expertise, but a poor communicator.
100

03/01/2017
With my [...] diagnosis, I feel very fortunate to have Dr. Bensinger's expertise. I trust him completely.
 

01/18/2017
[...] his somewhat clinical approach and attitude is much appreciated.
100

11/18/2016
I love Dr. Bensinger.
100

10/26/2016
We were seeking a second opinion. Dr. B. did an excellent overview of possible treatment options and helped us eliminate a couple of them.
1922198886
 
Center for Blood Disorders and Stem Cell Transplantation
1221 Madison Street Floor 10
Seattle, WA 98104
206-215-1655